catalog number :
MBS2886246
products type :
ELISA Kit
products full name :
Rat Apolipoprotein B-100 ELISA Kit
products short name :
Apolipoprotein B-100
products name syn :
Apolipoprotein B-100; Apo B-100; Apob; Aa1064; Ac1-060
other names :
apolipoprotein B-100; Apolipoprotein B-100; apolipoprotein B-100; apolipoprotein B
products gene name :
Apob
other gene names :
Apob; Apob; Aa1064; Ac1-060; ApoB-48; ApoB-100; Apo B-100; Apo B-100; Apo B-48
uniprot entry name :
APOB_RAT
storage stability :
For long term storage, please store the entire kit at -20 degree C.
other info1 :
Samples: Serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
products description :
Intended Uses: This immunoassay kit allows for the in vitro quantitative determination of target antigen concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids. Principle of the Assay: The microtiter plate provided in this kit has been pre-coated with an antibody specific to target antigen. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for target antigen and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain target antigen, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of target antigen in the samples is then determined by comparing the O.D. of the samples to the standard curve.
ncbi acc num :
NP_062160.2
ncbi gb acc num :
NM_019287.2
ncbi mol weight :
536,024 Da
ncbi pathways :
Binding And Uptake Of Ligands By Scavenger Receptors Pathway (1333660); Cell Surface Interactions At The Vascular Wall Pathway (1333067); Chylomicron-mediated Lipid Transport Pathway (1333315); Fat Digestion And Absorption Pathway (194376); Fat Digestion And Absorption Pathway (194324); Hemostasis Pathway (1333034); LDL-mediated Lipid Transport Pathway (1333317); Lipid Digestion, Mobilization, And Transport Pathway (1333311); Lipoprotein Metabolism Pathway (1333314); Metabolism Pathway (1333271)
ncbi summary :
This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-L and apoB-H. Unlike the apoB-48 and apoB-100 structural equivalents in human, which are synthesized exclusively in the gut and liver, respectively, the rat apoBL isoform is also found in rat liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-L protein is produced after RNA editing of the apoB-H transcript at residue 2180 (CAA- UAA), resulting in the creation of a stop codon, and early translation termination. [provided by RefSeq, Jul 2008]
uniprot summary :
APOB: Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor. Defects in APOB are a cause of familial hypobetalipoproteinemia type 1 (FHBL1). A disorder characterized by highly reduced plasma concentrations of low density lipoproteins, and dietary fat malabsorption. Clinical presentation may vary from no symptoms to severe gastrointestinal and neurological dysfunction similar to abetalipoproteinemia. Defects in APOB are a cause of familial ligand-defective apolipoprotein B-100 (FDB). FDB is a dominantly inherited disorder of lipoprotein metabolism leading to hypercholesterolemia and increased proneness to coronary artery disease (CAD). The plasma cholesterol levels are dramatically elevated due to impaired clearance of LDL particles by defective APOB/E receptors. Defects in APOB associated with defects in other genes (polygenic) can contribute to hypocholesterolemia. Protein type: Secreted; Carrier; Secreted, signal peptide. Cellular Component: actin cytoskeleton; cell soma; chylomicron; cytoplasm; endoplasmic reticulum; extracellular space; Golgi apparatus; intracellular membrane-bound organelle; plasma membrane; vesicle membrane. Molecular Function: cholesterol transporter activity; heparin binding; lipid binding; lipid transporter activity; low-density lipoprotein receptor binding; phospholipid binding; protein binding. Biological Process: artery morphogenesis; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transport; fertilization; in utero embryonic development; lipid catabolic process; lipid metabolic process; lipid transport; lipoprotein biosynthetic process; lipoprotein catabolic process; lipoprotein metabolic process; lipoprotein transport; nervous system development; post-embryonic development; regulation of cholesterol biosynthetic process; response to carbohydrate stimulus; response to lipopolysaccharide; response to organic substance; response to selenium ion; response to virus; sperm motility; spermatogenesis; triacylglycerol catabolic process; triacylglycerol mobilization